Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-065745
Filing Date
2025-07-03
Accepted
2025-07-03 14:50:25
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 tm2519224-2_s3.htm S-3 436329
2 EXHIBIT 4.4 tm2519224d3_ex4-4.htm EX-4.4 373492
3 EXHIBIT 4.6 tm2519224d3_ex4-6.htm EX-4.6 121996
4 EXHIBIT 4.7 tm2519224d3_ex4-7.htm EX-4.7 120128
5 EXHIBIT 4.8 tm2519224d3_ex4-8.htm EX-4.8 97421
6 EXHIBIT 5.1 tm2519224d3_ex5-1.htm EX-5.1 27400
7 EXHIBIT 23.1 tm2519224d3_ex23-1.htm EX-23.1 1800
8 EXHIBIT 23.2 tm2519224d3_ex23-2.htm EX-23.2 1959
9 EX-FILING FEES tm2519224d3_ex-filingfees.htm EX-FILING FEES 54626
10 GRAPHIC tm2519224d3_ex5-1img001.jpg GRAPHIC 3079
11 GRAPHIC lg_alumis-4c.jpg GRAPHIC 9205
  Complete submission text file 0001104659-25-065745.txt   1253558
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288510 | Film No.: 251105181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)